Digital Health Platform Leverages AI and POC Testing for Improved CKD Diagnosis
Carna Health is revolutionizing CKD detection by integrating AI-driven analytics with real-time, point-of-care (POC) testing.
Read MorePosted by Andy Lundin | Feb 4, 2025 | Kidney Disease, Point-of-Care |
Carna Health is revolutionizing CKD detection by integrating AI-driven analytics with real-time, point-of-care (POC) testing.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Womens Health |
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MorePosted by Chris Wolski | Jan 15, 2025 | Miscellaneous |
Following a People-to-People trip to Cuba, CLP Chief Editor Chris Wolski gained a more nuanced view of the Cuban healthcare system.
Read MorePosted by Chris Wolski | Dec 26, 2024 | Pancreatic |
ClearNote Health collaborates with research teams in Southampton, UK, to use their Avantect Pancreatic Cancer Test in a large-scale study.
Read MorePosted by Andy Lundin | Dec 20, 2024 | Molecular Diagnostics, Pancreatic |
PharusDx announced a liquid biopsy test that uses microRNA and CA19-9 biomarkers to detect early-stage pancreatic cancer.
Read More